4//SEC Filing
HIG GP II INC 4
Accession 0001104659-11-018940
CIK 0001274644other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 5:10 PM ET
Size
15.0 KB
Accession
0001104659-11-018940
Insider Transaction Report
Form 4
TRANZYME INCTZYM
H.I.G. Ventures - Tranzyme, LLC
10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Purchase
Common Stock
2011-04-06$4.00/sh+812,500$3,250,000→ 3,002,291 total
HIG GP II INC
10% Owner
Transactions
- Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Purchase
Common Stock
2011-04-06$4.00/sh+812,500$3,250,000→ 3,002,291 total
MNAYMNEH SAMI
10% Owner
Transactions
- Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Purchase
Common Stock
2011-04-06$4.00/sh+812,500$3,250,000→ 3,002,291 total
TAMER ANTHONY
10% Owner
Transactions
- Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total - Purchase
Common Stock
2011-04-06$4.00/sh+812,500$3,250,000→ 3,002,291 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying)
Davidson Aaron
Director
Transactions
- Purchase
Common Stock
2011-04-06$4.00/sh+812,500$3,250,000→ 3,002,291 total - Conversion
Series A Convertible Preferred Stock
2011-04-06−15,328,551→ 0 total→ Common Stock (2,189,791 underlying) - Conversion
Common Stock
2011-04-06+2,189,791→ 2,189,791 total
Footnotes (3)
- [F1]Each share of the Issuer's Series A Convertible Preferred Stock automatically converted, for no additional consideration, into shares of Common Stock prior to the closing of the Issuer's initial public offering on a 7-for-1 basis, reflecting a 1-for-7 reverse stock split which became effective on March 31, 2011.
- [F2]These securities are owned of record by H.I.G. Ventures - Tranzyme, LLC ("HIG LLC"). H.I.G. - GPII, Inc. ("GP II") is the manager of HIG LLC and has shared voting and dispositive power of the securities held by HIG LLC, but GP II disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. The co-presidents, directors, and sole shareholders of GP II having shared voting and dispositive power over these securities are Sami Mnaymneh and Anthony Tamer, each of whom disclaims beneficial ownership of such securities except to the extent of his pecuniary interests therein.
- [F3]These shares were purchased in the Issuer's initial public offering.
Documents
Issuer
TRANZYME INC
CIK 0001274644
Entity typeother
Related Parties
1- filerCIK 0001173671
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 5:10 PM ET
- Size
- 15.0 KB